Pfizer (PFE) Ratios
Pfizer Ratios
MX:PFE's free cash flow for Q2 2026 was $302.00M. For the 2026 fiscal year, MX:PFE's free cash flow was decreased by $-533.00M and operating cash flow was $835.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.16 | 1.17 | 0.91 | 1.22 | 1.40 |
| Quick Ratio | 0.87 | 0.92 | 0.69 | 1.00 | 1.19 |
| Cash Ratio | 0.03 | 0.02 | 0.06 | 0.01 | 0.05 |
| Solvency Ratio | 0.12 | 0.12 | 0.06 | 0.36 | 0.26 |
| Operating Cash Flow Ratio | 0.32 | 0.30 | 0.18 | 0.69 | 0.76 |
| Short-Term Operating Cash Flow Coverage | 3.36 | 1.83 | 0.84 | 9.98 | 14.54 |
| Net Current Asset Value | $ -78.49B | $ -74.54B | $ -93.88B | $ -50.03B | $ -44.32B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.32 | 0.31 | 0.31 | 0.18 | 0.20 |
| Debt-to-Equity Ratio | 0.78 | 0.76 | 0.80 | 0.36 | 0.48 |
| Debt-to-Capital Ratio | 0.44 | 0.43 | 0.44 | 0.27 | 0.32 |
| Long-Term Debt-to-Capital Ratio | 0.42 | 0.39 | 0.40 | 0.25 | 0.31 |
| Financial Leverage Ratio | 2.41 | 2.42 | 2.54 | 2.06 | 2.35 |
| Debt Service Coverage Ratio | 2.77 | 1.81 | 0.85 | 9.04 | 8.19 |
| Interest Coverage Ratio | 6.52 | 5.33 | 2.40 | 30.33 | 16.11 |
| Debt to Market Cap | 0.46 | 0.43 | 0.44 | 0.12 | 0.11 |
| Interest Debt Per Share | 12.33 | 12.37 | 12.95 | 6.44 | 6.84 |
| Net Debt to EBITDA | 3.95 | 3.64 | 7.11 | 0.84 | 1.14 |
| Profitability Margins | |||||
| Gross Profit Margin | 74.33% | 65.77% | 50.95% | 61.89% | 57.67% |
| EBIT Margin | 16.29% | 17.47% | 5.49% | 35.85% | 31.50% |
| EBITDA Margin | 26.82% | 28.49% | 16.05% | 40.90% | 37.88% |
| Operating Profit Margin | 27.82% | 25.91% | 8.89% | 37.43% | 25.58% |
| Pretax Profit Margin | 12.02% | 12.61% | 1.78% | 34.61% | 29.91% |
| Net Profit Margin | 12.42% | 12.60% | 3.58% | 31.26% | 27.25% |
| Continuous Operations Profit Margin | 12.44% | 12.65% | 3.65% | 31.30% | 27.63% |
| Net Income Per EBT | 103.34% | 99.96% | 201.61% | 90.31% | 91.10% |
| EBT Per EBIT | 43.20% | 48.67% | 19.99% | 92.49% | 116.92% |
| Return on Assets (ROA) | 3.73% | 3.76% | 0.94% | 15.90% | 12.20% |
| Return on Equity (ROE) | 8.99% | 9.09% | 2.40% | 32.79% | 28.69% |
| Return on Capital Employed (ROCE) | 10.17% | 9.67% | 2.96% | 24.21% | 14.98% |
| Return on Invested Capital (ROIC) | 9.97% | 9.28% | 2.80% | 21.49% | 13.62% |
| Return on Tangible Assets | 9.34% | 8.97% | 2.27% | 30.61% | 20.67% |
| Earnings Yield | 5.49% | 5.34% | 1.31% | 10.92% | 6.70% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.95 | 4.31 | 3.83 | 6.91 | 5.16 |
| Payables Turnover | 3.07 | 3.87 | 4.35 | 5.62 | 6.17 |
| Inventory Turnover | 1.51 | 2.01 | 2.87 | 4.26 | 3.80 |
| Fixed Asset Turnover | 2.91 | 3.46 | 3.14 | 6.17 | 5.46 |
| Asset Turnover | 0.30 | 0.30 | 0.26 | 0.51 | 0.45 |
| Working Capital Turnover Ratio | 9.43 | 43.85 | 25.56 | 7.68 | 6.21 |
| Cash Conversion Cycle | 215.39 | 172.21 | 138.74 | 73.59 | 107.62 |
| Days of Sales Outstanding | 92.39 | 84.77 | 95.27 | 52.86 | 70.70 |
| Days of Inventory Outstanding | 242.03 | 181.84 | 127.31 | 85.72 | 96.08 |
| Days of Payables Outstanding | 119.04 | 94.40 | 83.84 | 64.99 | 59.16 |
| Operating Cycle | 334.43 | 266.61 | 222.57 | 138.58 | 166.78 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.06 | 2.25 | 1.54 | 5.22 | 5.82 |
| Free Cash Flow Per Share | 1.60 | 1.74 | 0.85 | 4.64 | 5.33 |
| Dividend Paid and CapEx Coverage Ratio | 0.94 | 1.03 | 0.66 | 2.40 | 2.85 |
| Capital Expenditure Coverage Ratio | 4.45 | 4.38 | 2.23 | 9.04 | 12.02 |
| Operating Cash Flow Coverage Ratio | 0.17 | 0.19 | 0.12 | 0.84 | 0.88 |
| Operating Cash Flow to Sales Ratio | 0.19 | 0.20 | 0.15 | 0.29 | 0.40 |
| Free Cash Flow Yield | 6.41% | 6.55% | 2.95% | 9.06% | 9.03% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 18.31 | 18.68 | 76.17 | 9.16 | 14.93 |
| Price-to-Sales (P/S) Ratio | 2.26 | 2.36 | 2.73 | 2.86 | 4.07 |
| Price-to-Book (P/B) Ratio | 1.64 | 1.70 | 1.83 | 3.00 | 4.28 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 15.59 | 15.28 | 33.90 | 11.04 | 11.07 |
| Price-to-Operating Cash Flow Ratio | 12.09 | 11.79 | 18.67 | 9.82 | 10.15 |
| Price-to-Earnings Growth (PEG) Ratio | -4.33 | 0.07 | -0.82 | 0.22 | 0.11 |
| Enterprise Value Multiple | 12.38 | 11.93 | 24.11 | 7.84 | 11.88 |
| Enterprise Value | 207.77B | 216.22B | 230.45B | 321.80B | 365.79B |
| EV to EBITDA | 12.38 | 11.93 | 24.11 | 7.84 | 11.88 |
| EV to Sales | 3.32 | 3.40 | 3.87 | 3.21 | 4.50 |
| EV to Free Cash Flow | 22.89 | 21.98 | 48.08 | 12.36 | 12.25 |
| EV to Operating Cash Flow | 17.75 | 16.97 | 26.49 | 11.00 | 11.23 |
| Tangible Book Value Per Share | -6.73 | -6.26 | -7.69 | 0.21 | 0.56 |
| Shareholders’ Equity Per Share | 15.22 | 15.57 | 15.77 | 17.06 | 13.78 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.04 | -0.00 | -1.05 | 0.10 | 0.08 |
| Revenue Per Share | 11.01 | 11.23 | 10.55 | 17.89 | 14.51 |
| Net Income Per Share | 1.37 | 1.42 | 0.38 | 5.59 | 3.95 |
| Tax Burden | 1.03 | 1.00 | 2.02 | 0.90 | 0.91 |
| Interest Burden | 0.74 | 0.72 | 0.32 | 0.97 | 0.95 |
| Research & Development to Revenue | 0.17 | 0.17 | 0.18 | 0.11 | 0.17 |
| SG&A to Revenue | 0.22 | 0.23 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Income Quality | 1.50 | 1.58 | 4.01 | 0.93 | 1.45 |
Currency in USD